Value-Based Care

For a teen with rare genetic conditions, a sunken chest was a daily struggle. A pioneering surgery didn't just fix it—it gave him a new life.

The AMA appoints Dr. John Wigneswaran, a physician-exec from Walmart and UnitedHealth, signaling a strategic shift toward corporate-style operations.

A new study reveals a sharp drop in prescription fills at just $35, highlighting a critical affordability crisis that even insured patients can't escape.

With a novel two-in-one device and a $41M funding boost, Cagent Vascular is poised to challenge the standard of care for complex calcified arteries.

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

Nourish lands $100M to expand its AI-powered metabolic clinic, blending dietitian care with technology to reverse chronic disease and cut healthcare costs.

A new partnership embeds specialty drug ordering into clinic software, promising to boost efficiency and patient care in the booming infusion market.

With a new outreach VP, Professional Case Management aims to expand critical home care for former nuclear workers navigating a complex federal benefits program.

A new 'bioadaptor' implant that restores artery function shows an 88% drop in cardiac deaths compared to stents, heralding a new dawn for heart care.

Beyond the call bell, integrated systems are the new nervous system of modern hospitals, boosting patient safety, staff efficiency, and overall care.

Europe's top cancer center adopts an AI orchestration platform, aiming to cut wait times, boost efficiency, and reshape the patient journey.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

A landmark program merges AI health monitoring and on-site doctors, allowing pilgrims with chronic conditions to safely perform Umrah for the first time.

SERB Pharma's acquisition of Idefirix® rights offers new hope to thousands of highly sensitized patients previously unable to receive a kidney transplant.

A Santa Barbara senior community's immersive 'Star Room' wins a top award, signaling a major shift in technology-driven dementia care and well-being.

Mineralys Therapeutics' lorundrostat shows promise for millions with uncontrolled blood pressure and kidney disease, targeting a key hormonal driver.

A new scholarship champions empathy in medicine, founded by a doctor whose own license has recently come under emergency suspension by state regulators.

Kidney care giant DaVita unveils ambitious 2030 targets for transplants, health equity, and sustainability, raising the bar for the healthcare industry.

EyePromise launches Heyedrate Clinical, a new artificial tear with European-proven tech, promising longer relief for millions suffering from dry eye.

A strategic investment from Olayan Financing Company positions MS Pharma to dominate the MENA biologics market, fueling Saudi Arabia's Vision 2030 goals.